サンプル依頼リスト カート
  • English
デフォルト表紙
市場調査レポート
商品コード
1753929

内視鏡的逆行性胆管膵管造影の市場レポート：製品、手順、エンドユーザー、地域別、2025年～2033年

Endoscopic Retrograde Cholangiopancreatography Market Report by Product, Procedure, End User, and Region 2025-2033

出版日
発行
IMARC
ページ情報
英文 148 Pages
納期
2～3営業日
カスタマイズ可能
価格
価格表記: USDを日本円(税抜)に換算
本日の銀行送金レート: 1USD=145.80円
内視鏡的逆行性胆管膵管造影の市場レポート：製品、手順、エンドユーザー、地域別、2025年～2033年
出版日: 2025年06月02日
発行: IMARC
ページ情報: 英文 148 Pages
納期: 2～3営業日
GIIご利用のメリット
  • 全表示
  • 概要
  • 図表
  • 目次
概要

世界の内視鏡的逆行性胆管膵管造影市場規模は2024年に17億米ドルに達しました。今後、IMARC Groupは、市場は2033年までに28億米ドルに達し、2025-2033年の成長率（CAGR）は5.58％になると予測しています。

内視鏡的逆行性胆管膵管造影（ERCP）は、肝臓、胆嚢、胆管、膵臓の異常を診断・治療する画像診断技術です。X線と、食道、口、胃を通る長くて柔軟な軽量の内視鏡チューブを組み合わせる。胆管の閉塞、結石、感染症、腫瘍、膵管からの体液漏れを発見するのに役立ちます。その上、開腹手術よりも侵襲が少なく、膵胆道系についてより詳細で正確な情報を得ることができます。その結果、嚥下障害、下痢、体重減少、胸やけ、血便などを調べるための内視鏡治療機器の需要が世界中で高まっています。

内視鏡的逆行性胆管膵管造影市場動向：

世界人口の増加と、バレット病、胆道疾患、肝臓疾患、クローン病、炎症性腸疾患、消化性潰瘍疾患、胃食道逆流症（GERD）など、さまざまな慢性胃腸（GI）疾患や絶え間ない胆道疾患の有病率の上昇は、市場にプラスの影響を与える主な要因の1つとなっています。加えて、良性の膵臓腫瘍や肝腫瘍の発生が、特に老年人口の間で増加していること、世界中でがんの発生が増加していることが、市場を牽引しています。これに伴い、病院や診断センターの拡大が画像診断技術の必要性を高めており、市場の成長を後押ししています。さらに、先進的な内視鏡機器や内視鏡研究の改善に向けた各国の政府やヘルスケア組織による投資の増加が、市場の成長を強化しています。これとは別に、迅速な回復と最小限の痛みを目的とした低侵襲手術に対する消費者の嗜好の変化や、括約筋切開器のようなERCP機器に対する認知度の高まりが、良好な市場見通しを提供しています。さらに、ヘルスケアインフラの継続的な改善と医療ツーリズムの大幅な増加が市場成長を促進すると予想されます。

本レポートで扱う主な質問

  • 内視鏡的逆行性胆管膵管造影の世界市場規模は？
  • 内視鏡的逆行性胆管膵管造影の世界市場の予想成長率は（2025年から2033年）？
  • 内視鏡的逆行性胆管膵管造影の世界市場を牽引する主要因は？
  • 内視鏡的逆行性胆管膵管造影の世界市場におけるCOVID-19の影響は？
  • 内視鏡的逆行性胆管膵管造影の世界市場における製品別の市場内訳は？
  • 内視鏡的逆行性胆管膵管造影の世界市場における手順別の市場内訳は？
  • 内視鏡的逆行性胆管膵管造影の世界市場におけるエンドユーザー別の市場内訳は？
  • 内視鏡的逆行性胆管膵管造影の世界市場における主要地域は？
  • 内視鏡的逆行性胆管膵管造影の世界市場における主要企業は？

目次

第1章 序文

第2章 調査範囲と調査手法

  • 調査の目的
  • ステークホルダー
  • データソース
    • 一次情報
    • 二次情報
  • 市場推定
    • ボトムアップアプローチ
    • トップダウンアプローチ
  • 調査手法

第3章 エグゼクティブサマリー

第4章 イントロダクション

  • 概要
  • 主要業界動向

第5章 世界の内視鏡的逆行性胆管膵管造影市場

  • 市場概要
  • 市場実績
  • COVID-19の影響
  • 市場予測

第6章 市場内訳：製品別

  • 内視鏡
  • 内視鏡治療装置
    • 主要セグメント
      • 括約筋切開術
      • 砕石器
      • ステント
      • その他
  • 可視化システム
  • エネルギーデバイス
  • その他

第7章 市場内訳：手順別

  • 胆道括約筋切開術
  • 胆管ステント留置術
  • 胆道拡張症
  • 膵括約筋切開術
  • 膵管ステント留置術
  • 膵管拡張

第8章 市場内訳：エンドユーザー別

  • 病院と診療所
  • 外来手術センター
  • その他

第9章 市場内訳：地域別

  • 北米
    • 米国
    • カナダ
  • アジア太平洋地域
    • 中国
    • 日本
    • インド
    • 韓国
    • オーストラリア
    • インドネシア
    • その他
  • 欧州
    • ドイツ
    • フランス
    • 英国
    • イタリア
    • スペイン
    • ロシア
    • その他
  • ラテンアメリカ
    • ブラジル
    • メキシコ
    • その他
  • 中東・アフリカ
    • 市場内訳：国別

第10章 SWOT分析

  • 概要
  • 強み
  • 弱み
  • 機会
  • 脅威

第11章 バリューチェーン分析

第12章 ポーターのファイブフォース分析

  • 概要
  • 買い手の交渉力
  • 供給企業の交渉力
  • 競合の程度
  • 新規参入業者の脅威
  • 代替品の脅威

第13章 価格分析

第14章 競合情勢

  • 市場構造
  • 主要企業
  • 主要企業のプロファイル
    • Boston Scientific Corporation
    • CONMED Corporation
    • Cook Group Incorporated
    • Fujifilm Holdings Corporation
    • Hobbs Medical Inc.
    • Johnson & Johnson
    • Medi-Globe GmbH
    • Medtronic plc
    • Olympus Corporation
    • Shaili Endoscopy
    • Steris Corporation
    • Telemed Systems Inc.
図表

List of Figures

  • Figure 1: Global: Endoscopic Retrograde Cholangiopancreatography Market: Major Drivers and Challenges
  • Figure 2: Global: Endoscopic Retrograde Cholangiopancreatography Market: Sales Value (in Billion USD), 2019-2024
  • Figure 3: Global: Endoscopic Retrograde Cholangiopancreatography Market Forecast: Sales Value (in Billion USD), 2025-2033
  • Figure 4: Global: Endoscopic Retrograde Cholangiopancreatography Market: Breakup by Product (in %), 2024
  • Figure 5: Global: Endoscopic Retrograde Cholangiopancreatography Market: Breakup by Procedure (in %), 2024
  • Figure 6: Global: Endoscopic Retrograde Cholangiopancreatography Market: Breakup by End User (in %), 2024
  • Figure 7: Global: Endoscopic Retrograde Cholangiopancreatography Market: Breakup by Region (in %), 2024
  • Figure 8: Global: Endoscopic Retrograde Cholangiopancreatography (Endoscope) Market: Sales Value (in Million USD), 2019 & 2024
  • Figure 9: Global: Endoscopic Retrograde Cholangiopancreatography (Endoscope) Market Forecast: Sales Value (in Million USD), 2025-2033
  • Figure 10: Global: Endoscopic Retrograde Cholangiopancreatography (Endotherapy Devices) Market: Sales Value (in Million USD), 2019 & 2024
  • Figure 11: Global: Endoscopic Retrograde Cholangiopancreatography (Endotherapy Devices) Market Forecast: Sales Value (in Million USD), 2025-2033
  • Figure 12: Global: Endoscopic Retrograde Cholangiopancreatography (Visualization Systems) Market: Sales Value (in Million USD), 2019 & 2024
  • Figure 13: Global: Endoscopic Retrograde Cholangiopancreatography (Visualization Systems) Market Forecast: Sales Value (in Million USD), 2025-2033
  • Figure 14: Global: Endoscopic Retrograde Cholangiopancreatography (Energy Devices) Market: Sales Value (in Million USD), 2019 & 2024
  • Figure 15: Global: Endoscopic Retrograde Cholangiopancreatography (Energy Devices) Market Forecast: Sales Value (in Million USD), 2025-2033
  • Figure 16: Global: Endoscopic Retrograde Cholangiopancreatography (Other Products) Market: Sales Value (in Million USD), 2019 & 2024
  • Figure 17: Global: Endoscopic Retrograde Cholangiopancreatography (Other Products) Market Forecast: Sales Value (in Million USD), 2025-2033
  • Figure 18: Global: Endoscopic Retrograde Cholangiopancreatography (Biliary Sphincterotomy) Market: Sales Value (in Million USD), 2019 & 2024
  • Figure 19: Global: Endoscopic Retrograde Cholangiopancreatography (Biliary Sphincterotomy) Market Forecast: Sales Value (in Million USD), 2025-2033
  • Figure 20: Global: Endoscopic Retrograde Cholangiopancreatography (Biliary Stenting) Market: Sales Value (in Million USD), 2019 & 2024
  • Figure 21: Global: Endoscopic Retrograde Cholangiopancreatography (Biliary Stenting) Market Forecast: Sales Value (in Million USD), 2025-2033
  • Figure 22: Global: Endoscopic Retrograde Cholangiopancreatography (Biliary Dilatation) Market: Sales Value (in Million USD), 2019 & 2024
  • Figure 23: Global: Endoscopic Retrograde Cholangiopancreatography (Biliary Dilatation) Market Forecast: Sales Value (in Million USD), 2025-2033
  • Figure 24: Global: Endoscopic Retrograde Cholangiopancreatography (Pancreatic Sphincterotomy) Market: Sales Value (in Million USD), 2019 & 2024
  • Figure 25: Global: Endoscopic Retrograde Cholangiopancreatography (Pancreatic Sphincterotomy) Market Forecast: Sales Value (in Million USD), 2025-2033
  • Figure 26: Global: Endoscopic Retrograde Cholangiopancreatography (Pancreatic Duct Stenting) Market: Sales Value (in Million USD), 2019 & 2024
  • Figure 27: Global: Endoscopic Retrograde Cholangiopancreatography (Pancreatic Duct Stenting) Market Forecast: Sales Value (in Million USD), 2025-2033
  • Figure 28: Global: Endoscopic Retrograde Cholangiopancreatography (Pancreatic Duct Dilatation) Market: Sales Value (in Million USD), 2019 & 2024
  • Figure 29: Global: Endoscopic Retrograde Cholangiopancreatography (Pancreatic Duct Dilatation) Market Forecast: Sales Value (in Million USD), 2025-2033
  • Figure 30: Global: Endoscopic Retrograde Cholangiopancreatography (Hospitals and Clinics) Market: Sales Value (in Million USD), 2019 & 2024
  • Figure 31: Global: Endoscopic Retrograde Cholangiopancreatography (Hospitals and Clinics) Market Forecast: Sales Value (in Million USD), 2025-2033
  • Figure 32: Global: Endoscopic Retrograde Cholangiopancreatography (Ambulatory Surgery Centers) Market: Sales Value (in Million USD), 2019 & 2024
  • Figure 33: Global: Endoscopic Retrograde Cholangiopancreatography (Ambulatory Surgery Centers) Market Forecast: Sales Value (in Million USD), 2025-2033
  • Figure 34: Global: Endoscopic Retrograde Cholangiopancreatography (Other End Users) Market: Sales Value (in Million USD), 2019 & 2024
  • Figure 35: Global: Endoscopic Retrograde Cholangiopancreatography (Other End Users) Market Forecast: Sales Value (in Million USD), 2025-2033
  • Figure 36: North America: Endoscopic Retrograde Cholangiopancreatography Market: Sales Value (in Million USD), 2019 & 2024
  • Figure 37: North America: Endoscopic Retrograde Cholangiopancreatography Market Forecast: Sales Value (in Million USD), 2025-2033
  • Figure 38: United States: Endoscopic Retrograde Cholangiopancreatography Market: Sales Value (in Million USD), 2019 & 2024
  • Figure 39: United States: Endoscopic Retrograde Cholangiopancreatography Market Forecast: Sales Value (in Million USD), 2025-2033
  • Figure 40: Canada: Endoscopic Retrograde Cholangiopancreatography Market: Sales Value (in Million USD), 2019 & 2024
  • Figure 41: Canada: Endoscopic Retrograde Cholangiopancreatography Market Forecast: Sales Value (in Million USD), 2025-2033
  • Figure 42: Asia-Pacific: Endoscopic Retrograde Cholangiopancreatography Market: Sales Value (in Million USD), 2019 & 2024
  • Figure 43: Asia-Pacific: Endoscopic Retrograde Cholangiopancreatography Market Forecast: Sales Value (in Million USD), 2025-2033
  • Figure 44: China: Endoscopic Retrograde Cholangiopancreatography Market: Sales Value (in Million USD), 2019 & 2024
  • Figure 45: China: Endoscopic Retrograde Cholangiopancreatography Market Forecast: Sales Value (in Million USD), 2025-2033
  • Figure 46: Japan: Endoscopic Retrograde Cholangiopancreatography Market: Sales Value (in Million USD), 2019 & 2024
  • Figure 47: Japan: Endoscopic Retrograde Cholangiopancreatography Market Forecast: Sales Value (in Million USD), 2025-2033
  • Figure 48: India: Endoscopic Retrograde Cholangiopancreatography Market: Sales Value (in Million USD), 2019 & 2024
  • Figure 49: India: Endoscopic Retrograde Cholangiopancreatography Market Forecast: Sales Value (in Million USD), 2025-2033
  • Figure 50: South Korea: Endoscopic Retrograde Cholangiopancreatography Market: Sales Value (in Million USD), 2019 & 2024
  • Figure 51: South Korea: Endoscopic Retrograde Cholangiopancreatography Market Forecast: Sales Value (in Million USD), 2025-2033
  • Figure 52: Australia: Endoscopic Retrograde Cholangiopancreatography Market: Sales Value (in Million USD), 2019 & 2024
  • Figure 53: Australia: Endoscopic Retrograde Cholangiopancreatography Market Forecast: Sales Value (in Million USD), 2025-2033
  • Figure 54: Indonesia: Endoscopic Retrograde Cholangiopancreatography Market: Sales Value (in Million USD), 2019 & 2024
  • Figure 55: Indonesia: Endoscopic Retrograde Cholangiopancreatography Market Forecast: Sales Value (in Million USD), 2025-2033
  • Figure 56: Others: Endoscopic Retrograde Cholangiopancreatography Market: Sales Value (in Million USD), 2019 & 2024
  • Figure 57: Others: Endoscopic Retrograde Cholangiopancreatography Market Forecast: Sales Value (in Million USD), 2025-2033
  • Figure 58: Europe: Endoscopic Retrograde Cholangiopancreatography Market: Sales Value (in Million USD), 2019 & 2024
  • Figure 59: Europe: Endoscopic Retrograde Cholangiopancreatography Market Forecast: Sales Value (in Million USD), 2025-2033
  • Figure 60: Germany: Endoscopic Retrograde Cholangiopancreatography Market: Sales Value (in Million USD), 2019 & 2024
  • Figure 61: Germany: Endoscopic Retrograde Cholangiopancreatography Market Forecast: Sales Value (in Million USD), 2025-2033
  • Figure 62: France: Endoscopic Retrograde Cholangiopancreatography Market: Sales Value (in Million USD), 2019 & 2024
  • Figure 63: France: Endoscopic Retrograde Cholangiopancreatography Market Forecast: Sales Value (in Million USD), 2025-2033
  • Figure 64: United Kingdom: Endoscopic Retrograde Cholangiopancreatography Market: Sales Value (in Million USD), 2019 & 2024
  • Figure 65: United Kingdom: Endoscopic Retrograde Cholangiopancreatography Market Forecast: Sales Value (in Million USD), 2025-2033
  • Figure 66: Italy: Endoscopic Retrograde Cholangiopancreatography Market: Sales Value (in Million USD), 2019 & 2024
  • Figure 67: Italy: Endoscopic Retrograde Cholangiopancreatography Market Forecast: Sales Value (in Million USD), 2025-2033
  • Figure 68: Spain: Endoscopic Retrograde Cholangiopancreatography Market: Sales Value (in Million USD), 2019 & 2024
  • Figure 69: Spain: Endoscopic Retrograde Cholangiopancreatography Market Forecast: Sales Value (in Million USD), 2025-2033
  • Figure 70: Russia: Endoscopic Retrograde Cholangiopancreatography Market: Sales Value (in Million USD), 2019 & 2024
  • Figure 71: Russia: Endoscopic Retrograde Cholangiopancreatography Market Forecast: Sales Value (in Million USD), 2025-2033
  • Figure 72: Others: Endoscopic Retrograde Cholangiopancreatography Market: Sales Value (in Million USD), 2019 & 2024
  • Figure 73: Others: Endoscopic Retrograde Cholangiopancreatography Market Forecast: Sales Value (in Million USD), 2025-2033
  • Figure 74: Latin America: Endoscopic Retrograde Cholangiopancreatography Market: Sales Value (in Million USD), 2019 & 2024
  • Figure 75: Latin America: Endoscopic Retrograde Cholangiopancreatography Market Forecast: Sales Value (in Million USD), 2025-2033
  • Figure 76: Brazil: Endoscopic Retrograde Cholangiopancreatography Market: Sales Value (in Million USD), 2019 & 2024
  • Figure 77: Brazil: Endoscopic Retrograde Cholangiopancreatography Market Forecast: Sales Value (in Million USD), 2025-2033
  • Figure 78: Mexico: Endoscopic Retrograde Cholangiopancreatography Market: Sales Value (in Million USD), 2019 & 2024
  • Figure 79: Mexico: Endoscopic Retrograde Cholangiopancreatography Market Forecast: Sales Value (in Million USD), 2025-2033
  • Figure 80: Others: Endoscopic Retrograde Cholangiopancreatography Market: Sales Value (in Million USD), 2019 & 2024
  • Figure 81: Others: Endoscopic Retrograde Cholangiopancreatography Market Forecast: Sales Value (in Million USD), 2025-2033
  • Figure 82: Middle East and Africa: Endoscopic Retrograde Cholangiopancreatography Market: Sales Value (in Million USD), 2019 & 2024
  • Figure 83: Middle East and Africa: Endoscopic Retrograde Cholangiopancreatography Market: Breakup by Country (in %), 2024
  • Figure 84: Middle East and Africa: Endoscopic Retrograde Cholangiopancreatography Market Forecast: Sales Value (in Million USD), 2025-2033
  • Figure 85: Global: Endoscopic Retrograde Cholangiopancreatography Industry: SWOT Analysis
  • Figure 86: Global: Endoscopic Retrograde Cholangiopancreatography Industry: Value Chain Analysis
  • Figure 87: Global: Endoscopic Retrograde Cholangiopancreatography Industry: Porter's Five Forces Analysis

List of Tables

  • Table 1: Global: Endoscopic Retrograde Cholangiopancreatography Market: Key Industry Highlights, 2024 and 2033
  • Table 2: Global: Endoscopic Retrograde Cholangiopancreatography Market Forecast: Breakup by Product (in Million USD), 2025-2033
  • Table 3: Global: Endoscopic Retrograde Cholangiopancreatography Market Forecast: Breakup by Procedure (in Million USD), 2025-2033
  • Table 4: Global: Endoscopic Retrograde Cholangiopancreatography Market Forecast: Breakup by End User (in Million USD), 2025-2033
  • Table 5: Global: Endoscopic Retrograde Cholangiopancreatography Market Forecast: Breakup by Region (in Million USD), 2025-2033
  • Table 6: Global: Endoscopic Retrograde Cholangiopancreatography Market: Competitive Structure
  • Table 7: Global: Endoscopic Retrograde Cholangiopancreatography Market: Key Players
目次
Product Code: SR112025A6442

The global endoscopic retrograde cholangiopancreatography market size reached USD 1.7 Billion in 2024. Looking forward, IMARC Group expects the market to reach USD 2.8 Billion by 2033, exhibiting a growth rate (CAGR) of 5.58% during 2025-2033.

Endoscopic retrograde cholangiopancreatography (ERCP) is an imaging technique that diagnoses and treats abnormalities in the liver, gallbladder, bile ducts, and pancreas. It combines X-rays and a long, flexible, lightweight endoscope tube that passes through the esophagus, mouth, and stomach. It helps detect blockages, stones, infections, and tumors in the bile duct and fluid leakage from the pancreatic duct. Besides this, it is a less invasive procedure than open surgery and provides more detailed and accurate information about the pancreaticobiliary system. As a result, the demand for endotherapy devices is increasing across the globe to investigate dysphagia, diarrhea, weight loss, heartburn, and stool blood.

Endoscopic Retrograde Cholangiopancreatography Market Trends:

The growing global population and the rising prevalence of various chronic gastrointestinal (GI) and incessant biliary medical disorders, including Barrett's disease, biliary, liver, Crohn's, inflammatory bowel, and peptic ulcer disease, and gastroesophageal reflux disorder (GERD), represent one of the key factors positively influencing the market. In addition, the increasing occurrence of benign pancreas and liver tumors, especially among the geriatric population, along with the growing occurrence of cancer across the globe, is driving the market. In line with this, the expansion of hospitals and diagnostic centers is increasing the need for imaging techniques propelling the market growth. Furthermore, rising investments by governments and healthcare organizations of various countries in advanced endoscopy devices and improve endoscopy research is strengthening the market growth. Apart from this, the shifting consumer preference toward minimally invasive surgeries for a speedy recovery and minimal pain and rising awareness about ERCP devices like sphincterotomes are offering a favorable market outlook. Moreover, continuous improvements in healthcare infrastructure and a considerable rise in medical tourism are expected to propel market growth.

Key Market Segmentation:

Breakup by Product:

  • Endoscope
  • Endotherapy Devices
    • Sphincterotomes
    • Lithotripter
    • Stents
    • Others
  • Visualization Systems
  • Energy Devices
  • Others

Breakup by Procedure:

  • Biliary Sphincterotomy
  • Biliary Stenting
  • Biliary Dilatation
  • Pancreatic Sphincterotomy
  • Pancreatic Duct Stenting
  • Pancreatic Duct Dilatation

Breakup by End User:

  • Hospitals and Clinics
  • Ambulatory Surgery Centers
  • Others

Breakup by Region:

  • North America
    • United States
    • Canada
  • Asia-Pacific
    • China
    • Japan
    • India
    • South Korea
    • Australia
    • Indonesia
    • Others
  • Europe
    • Germany
    • France
    • United Kingdom
    • Italy
    • Spain
    • Russia
    • Others
  • Latin America
    • Brazil
    • Mexico
    • Others
  • Middle East and Africa

Competitive Landscape:

The competitive landscape of the industry has also been examined along with the profiles of the key players being Boston Scientific Corporation, CONMED Corporation, Cook Group Incorporated, Fujifilm Holdings Corporation, Hobbs Medical Inc., Johnson & Johnson, Medi-Globe GmbH, Medtronic plc, Olympus Corporation, Shaili Endoscopy, Steris Corporation and Telemed Systems Inc.

Key Questions Answered in This Report

  • 1.How big is the global endoscopic retrograde cholangiopancreatography market?
  • 2.What is the expected growth rate of the global endoscopic retrograde cholangiopancreatography market during 2025-2033?
  • 3.What are the key factors driving the global endoscopic retrograde cholangiopancreatography market?
  • 4.What has been the impact of COVID-19 on the global endoscopic retrograde cholangiopancreatography market?
  • 5.What is the breakup of the global endoscopic retrograde cholangiopancreatography market based on the product?
  • 6.What is the breakup of the global endoscopic retrograde cholangiopancreatography market based on the procedure?
  • 7.What is the breakup of the global endoscopic retrograde cholangiopancreatography market based on the end user?
  • 8.What are the key regions in the global endoscopic retrograde cholangiopancreatography market?
  • 9.Who are the key players/companies in the global endoscopic retrograde cholangiopancreatography market?

Table of Contents

1 Preface

2 Scope and Methodology

  • 2.1 Objectives of the Study
  • 2.2 Stakeholders
  • 2.3 Data Sources
    • 2.3.1 Primary Sources
    • 2.3.2 Secondary Sources
  • 2.4 Market Estimation
    • 2.4.1 Bottom-Up Approach
    • 2.4.2 Top-Down Approach
  • 2.5 Forecasting Methodology

3 Executive Summary

4 Introduction

  • 4.1 Overview
  • 4.2 Key Industry Trends

5 Global Endoscopic Retrograde Cholangiopancreatography Market

  • 5.1 Market Overview
  • 5.2 Market Performance
  • 5.3 Impact of COVID-19
  • 5.4 Market Forecast

6 Market Breakup by Product

  • 6.1 Endoscope
    • 6.1.1 Market Trends
    • 6.1.2 Market Forecast
  • 6.2 Endotherapy Devices
    • 6.2.1 Market Trends
    • 6.2.2 Key Segments
      • 6.2.2.1 Sphincterotomes
      • 6.2.2.2 Lithotripter
      • 6.2.2.3 Stents
      • 6.2.2.4 Others
    • 6.2.3 Market Forecast
  • 6.3 Visualization Systems
    • 6.3.1 Market Trends
    • 6.3.2 Market Forecast
  • 6.4 Energy Devices
    • 6.4.1 Market Trends
    • 6.4.2 Market Forecast
  • 6.5 Others
    • 6.5.1 Market Trends
    • 6.5.2 Market Forecast

7 Market Breakup by Procedure

  • 7.1 Biliary Sphincterotomy
    • 7.1.1 Market Trends
    • 7.1.2 Market Forecast
  • 7.2 Biliary Stenting
    • 7.2.1 Market Trends
    • 7.2.2 Market Forecast
  • 7.3 Biliary Dilatation
    • 7.3.1 Market Trends
    • 7.3.2 Market Forecast
  • 7.4 Pancreatic Sphincterotomy
    • 7.4.1 Market Trends
    • 7.4.2 Market Forecast
  • 7.5 Pancreatic Duct Stenting
    • 7.5.1 Market Trends
    • 7.5.2 Market Forecast
  • 7.6 Pancreatic Duct Dilatation
    • 7.6.1 Market Trends
    • 7.6.2 Market Forecast

8 Market Breakup by End User

  • 8.1 Hospitals and Clinics
    • 8.1.1 Market Trends
    • 8.1.2 Market Forecast
  • 8.2 Ambulatory Surgery Centers
    • 8.2.1 Market Trends
    • 8.2.2 Market Forecast
  • 8.3 Others
    • 8.3.1 Market Trends
    • 8.3.2 Market Forecast

9 Market Breakup by Region

  • 9.1 North America
    • 9.1.1 United States
      • 9.1.1.1 Market Trends
      • 9.1.1.2 Market Forecast
    • 9.1.2 Canada
      • 9.1.2.1 Market Trends
      • 9.1.2.2 Market Forecast
  • 9.2 Asia-Pacific
    • 9.2.1 China
      • 9.2.1.1 Market Trends
      • 9.2.1.2 Market Forecast
    • 9.2.2 Japan
      • 9.2.2.1 Market Trends
      • 9.2.2.2 Market Forecast
    • 9.2.3 India
      • 9.2.3.1 Market Trends
      • 9.2.3.2 Market Forecast
    • 9.2.4 South Korea
      • 9.2.4.1 Market Trends
      • 9.2.4.2 Market Forecast
    • 9.2.5 Australia
      • 9.2.5.1 Market Trends
      • 9.2.5.2 Market Forecast
    • 9.2.6 Indonesia
      • 9.2.6.1 Market Trends
      • 9.2.6.2 Market Forecast
    • 9.2.7 Others
      • 9.2.7.1 Market Trends
      • 9.2.7.2 Market Forecast
  • 9.3 Europe
    • 9.3.1 Germany
      • 9.3.1.1 Market Trends
      • 9.3.1.2 Market Forecast
    • 9.3.2 France
      • 9.3.2.1 Market Trends
      • 9.3.2.2 Market Forecast
    • 9.3.3 United Kingdom
      • 9.3.3.1 Market Trends
      • 9.3.3.2 Market Forecast
    • 9.3.4 Italy
      • 9.3.4.1 Market Trends
      • 9.3.4.2 Market Forecast
    • 9.3.5 Spain
      • 9.3.5.1 Market Trends
      • 9.3.5.2 Market Forecast
    • 9.3.6 Russia
      • 9.3.6.1 Market Trends
      • 9.3.6.2 Market Forecast
    • 9.3.7 Others
      • 9.3.7.1 Market Trends
      • 9.3.7.2 Market Forecast
  • 9.4 Latin America
    • 9.4.1 Brazil
      • 9.4.1.1 Market Trends
      • 9.4.1.2 Market Forecast
    • 9.4.2 Mexico
      • 9.4.2.1 Market Trends
      • 9.4.2.2 Market Forecast
    • 9.4.3 Others
      • 9.4.3.1 Market Trends
      • 9.4.3.2 Market Forecast
  • 9.5 Middle East and Africa
    • 9.5.1 Market Trends
    • 9.5.2 Market Breakup by Country
    • 9.5.3 Market Forecast

10 SWOT Analysis

  • 10.1 Overview
  • 10.2 Strengths
  • 10.3 Weaknesses
  • 10.4 Opportunities
  • 10.5 Threats

11 Value Chain Analysis

12 Porters Five Forces Analysis

  • 12.1 Overview
  • 12.2 Bargaining Power of Buyers
  • 12.3 Bargaining Power of Suppliers
  • 12.4 Degree of Competition
  • 12.5 Threat of New Entrants
  • 12.6 Threat of Substitutes

13 Price Analysis

14 Competitive Landscape

  • 14.1 Market Structure
  • 14.2 Key Players
  • 14.3 Profiles of Key Players
    • 14.3.1 Boston Scientific Corporation
      • 14.3.1.1 Company Overview
      • 14.3.1.2 Product Portfolio
      • 14.3.1.3 Financials
      • 14.3.1.4 SWOT Analysis
    • 14.3.2 CONMED Corporation
      • 14.3.2.1 Company Overview
      • 14.3.2.2 Product Portfolio
      • 14.3.2.3 Financials
      • 14.3.2.4 SWOT Analysis
    • 14.3.3 Cook Group Incorporated
      • 14.3.3.1 Company Overview
      • 14.3.3.2 Product Portfolio
    • 14.3.4 Fujifilm Holdings Corporation
      • 14.3.4.1 Company Overview
      • 14.3.4.2 Product Portfolio
      • 14.3.4.3 Financials
      • 14.3.4.4 SWOT Analysis
    • 14.3.5 Hobbs Medical Inc.
      • 14.3.5.1 Company Overview
      • 14.3.5.2 Product Portfolio
    • 14.3.6 Johnson & Johnson
      • 14.3.6.1 Company Overview
      • 14.3.6.2 Product Portfolio
      • 14.3.6.3 Financials
      • 14.3.6.4 SWOT Analysis
    • 14.3.7 Medi-Globe GmbH
      • 14.3.7.1 Company Overview
      • 14.3.7.2 Product Portfolio
    • 14.3.8 Medtronic plc
      • 14.3.8.1 Company Overview
      • 14.3.8.2 Product Portfolio
      • 14.3.8.3 Financials
      • 14.3.8.4 SWOT Analysis
    • 14.3.9 Olympus Corporation
      • 14.3.9.1 Company Overview
      • 14.3.9.2 Product Portfolio
      • 14.3.9.3 Financials
      • 14.3.9.4 SWOT Analysis
    • 14.3.10 Shaili Endoscopy
      • 14.3.10.1 Company Overview
      • 14.3.10.2 Product Portfolio
    • 14.3.11 Steris Corporation
      • 14.3.11.1 Company Overview
      • 14.3.11.2 Product Portfolio
    • 14.3.12 Telemed Systems Inc.
      • 14.3.12.1 Company Overview
      • 14.3.12.2 Product Portfolio